KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $5.9 billion.

  • Exact Sciences' Liabilities and Shareholders Equity fell 113.88% to $5.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $23.3 billion, marking a year-over-year decrease of 955.15%. This contributed to the annual value of $5.9 billion for FY2025, which is 113.88% down from last year.
  • Per Exact Sciences' latest filing, its Liabilities and Shareholders Equity stood at $5.9 billion for Q4 2025, which was down 113.88% from $5.9 billion recorded in Q3 2025.
  • Exact Sciences' Liabilities and Shareholders Equity's 5-year high stood at $6.7 billion during Q3 2024, with a 5-year trough of $5.7 billion in Q1 2025.
  • For the 5-year period, Exact Sciences' Liabilities and Shareholders Equity averaged around $6.3 billion, with its median value being $6.4 billion (2023).
  • Per our database at Business Quant, Exact Sciences' Liabilities and Shareholders Equity surged by 5282.2% in 2021 and then tumbled by 1312.59% in 2025.
  • Exact Sciences' Liabilities and Shareholders Equity (Quarter) stood at $6.7 billion in 2021, then fell by 6.85% to $6.2 billion in 2022, then increased by 3.93% to $6.5 billion in 2023, then fell by 8.39% to $5.9 billion in 2024, then dropped by 1.14% to $5.9 billion in 2025.
  • Its Liabilities and Shareholders Equity was $5.9 billion in Q4 2025, compared to $5.9 billion in Q3 2025 and $5.8 billion in Q2 2025.